Serum antibodies in six-year-old children vaccinated in infancy with a haemophilus influenzas type b-tetanus toxoid conjugate vaccine

Pediatric Infectious Disease Journal

Volumn 15, Issue 2, 1996, Pages 170-172

  Claesson, Bo A ^a,e   Trollfors, Birger ^a   Anderson, Porter W ^c   Johansson, Jan ^b   Taranger, John ^a   Schneerson, Rachel ^d   Robbing, John B ^d  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b BORÅS HOSPITAL   (Sweden)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antibodies; Conjugate vaccine; Haemophilus influenzae type b; Persistence

Indexed keywords

DIPHTHERIA TETANUS TOXOID; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; TETANUS TOXOID;

ANTIBODY BLOOD LEVEL; ARTICLE; BACTERIAL INFECTION; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; IMMUNIZATION; IMMUNOGENICITY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; VACCINATION;

AGE FACTORS; ANTIBODIES, BACTERIAL; CHILD; CHILD, PRESCHOOL; DIPHTHERIA TOXOID; FOLLOW-UP STUDIES; HAEMOPHILUS INFECTIONS; HAEMOPHILUS VACCINES; HUMANS; IMMUNIZATION SCHEDULE; INFANT; SWEDEN; VACCINATION;

EID: 0030028896     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199602000-00016     Document Type: Article

References (13)

1. Robbins JB, Parke JC, Schneerson R, Whisnant JK. Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular antibodies. Pediatr Res 1973;7:103-10.
2. Käyhty H, Peltola H, Karanko V, Mäkelä PH. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzas type b. J Infect Dis 1983;147:1100.
3. Santosham M, Reid R, Ambrosino DM, et al. Prevention of Haemophilus infiuenzae type b infections in high-risk infants treated with bacterial polysaccharide immune globulin. N Engl J Med 1987;317:923-9.
4. Claesson BA, Schneerson R, Robbins JB, et al. Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus infiuenzae type b capsular polysaccharide-tetanus toxoid conjugate. J Pediatr 1989;114:97-100.
5. Claesson BA, Schneerson R, Lagergård T, et al. Persistence of serum antibodies elicited by Haemophilus infiuenzae type b-tetanus toxoid conjugate vaccine in infants vaccinated at 3, 5 and 12 months of age. Pediatr Infect Dis J 1991;10:560-4.
6. Anderson P. Intrinsic labeling of the capsular antigen of Haemophilus infiuenzae type b. J Immunol 1978;120:866-70.
7. Fothergill LD, Wright J. Influenzal meningitis: the relation of age incidence to bactericidal power of blood against the causal organism. J Immunol 1933;24:273-84.
8. Dahlberg T. Quantitation of antibodies to Haemophilus infiuenzae type b in humans by enzyme-linked immunosorbent assay. J Clin Microbiol 1981;13:1080-7.
9. Claesson BA, Lagergård T, Trollfors B, Gothefors L, Jodal U. Serum antibody response to capsular polysaccharide, outer membrane, and lipooligosaccharide in children with invasive Haemophilus infiuenzae type b infections. J Clin Microbiol 1987;25:2339-43.
10. Anderson P, Smith DH, Ingram DL, Wilkins J, Wehrle PF, Howie VM. Antibody to polyribophosphate of Haemophilus infiuenzae type b in infants and children: effect of immunization with polyribophosphate. J Infect Dis 1977;136(Suppl):S57-62.
11. Schneerson R, Robbins JB. Induction of serum Haemophilus infiuenzae type b capsular antibodies in adult volunteers fed cross-reacting Escherichia coli O75:K100:H5. N Engl J Med 1975;292:1093-6.
12. Argaman M, Liu TY, Robbins JB. Polyribitol phosphate: an antigen of four Gram positive bacteria cross-reactive with the capsular polysaccharide of Haemophilus infiuenzae type b. J Immunol 1974;112:649-55.
13. Handzel ZT, Schneerson R, Parke JC Jr, Robbins JB. Heteroimmunization to the capsular polysaccharide of Haemophilus infiuenzae type b induced by enteric bacteria. Infect Immun 1975;11:1045-52.